Patent №
US 6,190,864
Granted
2001-02-20
Filed 1994
Owner
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
+1 more
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
08221653
The present application features nucleic acid, peptide and antibody compositions relating to genotypes of hepatitis C virus and methods of using such compositions for diagnostic and therapeutic purposes.
AI classification
Evolutionary computation0.54
Vision0.23
Natural language0.07
AI hardware0.00
Machine learning0.00
Planning0.00
Speech0.00
Knowledge representation0.00
Ownership
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
correct · 341160974
GRIFOLS WORLDWIDE OPERATIONS LIMITED
correct · 341160974
From the same owner
REVERSE GENETICS SYSTEMSUS 10,610,584 · 2020High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal AssaysUS 9,365,885 · 2016PRLR-Specific Antibody and Uses ThereofUS 9,005,614 · 2015COMPOSITIONS FOR INDUCING IMMUNE RESPONSESUS 8,815,253 · 2014SUBSTITUTED IMIDAZOLE DERIVATIVESUS 8,735,599 · 2014ANTIBACTERIAL AGENTSUS 7,989,660 · 2011ANTIBACTERIAL AGENTSUS 7,358,359 · 2008